Display options
Cite
Haiducu C, Buzea A, Mirea LE, et al. The prevalence and the impact of sarcopenia in digestive cancers. A systematic review. Rom J Intern Med. 2021;59(4):328-344doi: 10.2478/rjim-2021-0026.
Haiducu, C., Buzea, A., Mirea, L. E., & Dan, G. A. (2021). The prevalence and the impact of sarcopenia in digestive cancers. A systematic review. Romanian journal of internal medicine = Revue roumaine de medecine interne, 59(4), 328-344. https://doi.org/10.2478/rjim-2021-0026
Haiducu, Carmen, et al. "The prevalence and the impact of sarcopenia in digestive cancers. A systematic review." Romanian journal of internal medicine = Revue roumaine de medecine interne vol. 59,4 (2021): 328-344. doi: https://doi.org/10.2478/rjim-2021-0026
Haiducu C, Buzea A, Mirea LE, Dan GA. The prevalence and the impact of sarcopenia in digestive cancers. A systematic review. Rom J Intern Med. 2021 Nov 20;59(4):328-344. doi: 10.2478/rjim-2021-0026. Print 2021 Dec 01. PMID: 34218540.
Copy Download .nbib Format: NLM
Share it on

Rom J Intern Med. 2021 Nov 20;59(4):328-344. doi: 10.2478/rjim-2021-0026. Print 2021 Dec 01.

The prevalence and the impact of sarcopenia in digestive cancers. A systematic review.

Romanian journal of internal medicine = Revue roumaine de medecine interne

Carmen Haiducu, Adrian Buzea, Liliana Elena Mirea, Gheorghe Andrei Dan

Affiliations

  1. Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  2. Cardiology, Clinical Hospital Colentina, Bucharest, Romania.
  3. Anesthesia and Intensive Care Unit, Emergency Clinical Hospital, Bucharest, Romania.

PMID: 34218540 DOI: 10.2478/rjim-2021-0026

[No abstract available.]

© 2021 Carmen Haiducu et al., published by Sciendo.

Keywords: abdominal muscles; chemotherapy; malnutrition; prevalence; sarcopenia; tomography

References

  1. 1. CRUZ-JENTOFT, A.J., BAHAT, G., BAUER, J., BOIRIE, Y., BRUYÈRE, O., CEDERHOLM, T., et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019;48(1):16–31. - PubMed
  2. 2. VON HAEHLING, S., MORLEY, J.E., ANKER, S.D. An overview of sarcopenia: Facts and numbers on prevalence and clinical impact. b.n. Available at: doi:10.1007/s13539-010-0014-2. - PubMed
  3. 3. HEYMSFIELD, S.B., WANG, Z.M., BAUMGARTNER, R.N., ROSS, R. Human body composition: Advances in models and methods. b.n.Available at: doi:10.1146/annurev.nutr.17.1.527. - PubMed
  4. 4. PRADO, C.M., LIEFFERS, J.R., MCCARGAR, L.J., REIMAN, T., SAWYER, M.B., MARTIN, L., et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7). - PubMed
  5. 5. RIER, H.N., JAGER, A., SLEIJFER, S., MAIER, A.B., LEVIN, M. The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature. Oncologist 2016;21(11). - PubMed
  6. 6. MALTAIS ML, DESROCHES J, DIONNE IJ. Changes in muscle mass and strength after menopause. J Musculoskelet Neuronal Interact. 2009;9(4):186–97. https://www.ncbi.nlm.nih.gov/pubmed/19949277. no date. - PubMed
  7. 7. GOODPASTER BH, PARK SW, HARRIS TB, KRITCHEVSKY SB, NEVITT M, SCHWARTZ AV, SIMONSICK EM, TYLAVSKY FA, VISSER M, NEWMAN AB. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A B no date. - PubMed
  8. 8. GALLAGHER D, VISSER M, DE MEERSMAN RE, SEPULVEDA D, BAUMGARTNER RN, PIERSON RN, HARRIS T, HEYMSFIELD SB. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol (1985). 1997;83(1):229–39. no date. - PubMed
  9. 9. https://www.visiblebody.com/learn/skeleton/appendicular-skeleton. - PubMed
  10. 10. NIRMALA RATHNAYAKE, GAYANI ALWIS LEKAMWASAM, J.L. AND S. Concordance between appendicular skeletal muscle mass measured with DXA and estimated with mathematical models in middle-aged women. Rathnayake al. J. Physiol. Anthropol. 3719 https://doi.org/10.1186/s40101-018-0179-5 no date. - PubMed
  11. 11. WANG J, THORNTON JC, KOLESNIK S, PIERSON RN JR. Anthropometry in body composition: an overview. Ann N Y Acad Sci. 2000;904:317–26. https://www.ncbi.nlm.nih.gov/pubmed/10865763. no date. - PubMed
  12. 12. ROLLAND, Y., CZERWINSKI, S., VAN KAN, G.A., MORLEY, J.E., CESARI, M., ONDER, G., et al. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. b.n.Available at: doi:10.1007/BF02982704. - PubMed
  13. 13. GROTENHUIS, B.A., SHAPIRO, J., VAN ADRICHEM, S., DE VRIES, M., KOEK, M., WIJNHOVEN, B.P.L., et al. Sarcopenia/Muscle Mass is not a Prognostic Factor for Short- and Long-Term Outcome After Esophagectomy for Cancer. World J. Surg. 2016;40(11). - PubMed
  14. 14. ZHUANG, C. LE, HUANG, D.D., PANG, W.Y., ZHOU, C.J., WANG, S.L., LOU, N., et al. Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: Analysis from a large-scale cohort. Med. (United States) 2016;95(13). - PubMed
  15. 15. MOHER, D., LIBERATI, A., TETZLAFF, J., ALTMAN, D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339(jul21 1):b2535–b2535. - PubMed
  16. 16. CHEN, L.-K., WOO, J., ASSANTACHAI, P., AUYEUNG, T.-W., CHOU, M.-Y., IIJIMA, K., et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J. Am. Med. Dir. Assoc. 2020;21(3):300–307.e2. - PubMed
  17. 17. WELLS, G., SHEA, B., O’CONNELL, D., PETERSON, J., WELCH, V., LOSOS, M., et al. The Newcastle–Ottawa Scale (NOQAS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis. Available at http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. The Ottawa Hospital. - PubMed
  18. 18. DIJKSTERHUIS, W.P.M., PRUIJT, M.J., VAN DER WOUDE, S.O., KLAASSEN, R., KURK, S.A., VAN OIJEN, M.G.H., et al. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy. J. Cachexia. Sarcopenia Muscle 2019;10(1). - PubMed
  19. 19. JÄRVINEN, T., ILONEN, I., KAUPPI, J., VOLMONEN, K., SALO, J., RÄSÄNEN, J. Low skeletal muscle mass in stented esophageal cancer predicts poor survival: A retrospective observational study. Thorac. Cancer 2018;9(11). - PubMed
  20. 20. LEE, J.S., KIM, Y.S., KIM, E.Y., JIN, W. Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer. PLoS One 2018;13(8). - PubMed
  21. 21. LIN, J., ZHANG, W., HUANG, Y., CHEN, W., WU, R., CHEN, X., et al. Sarcopenia is associated with the neutrophil/lymphocyte and platelet/lymphocyte ratios in operable gastric cancer patients: A prospective study. Cancer Manag. Res. 2018;10. - PubMed
  22. 22. CESPEDES FELICIANO, E.M., AVRUTIN, E., CAAN, B.J., BOROIAN, A., MOURTZAKIS, M. Screening for low muscularity in colorectal cancer patients: a valid, clinic-friendly approach that predicts mortality. J. Cachexia. Sarcopenia Muscle 2018;9(5):898–908. - PubMed
  23. 23. DOLAN, R.D., ALMASAUDI, A.S., DIEU, L.B., HORGAN, P.G., MCSORLEY, S.T., MCMILLAN, D.C. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer. J. Cachexia. Sarcopenia Muscle 2019;10(1):111–122. - PubMed
  24. 24. XIAO, J., CAAN, B.J., CESPEDES FELICIANO, E.M., MEYERHARDT, J.A., KROENKE, C.H., BARACOS, V.E., et al. The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic colorectal cancer. Am. J. Clin. Nutr. 2019;109(3):615–625. - PubMed
  25. 25. VASHI, P.G., GORSUCH, K., WAN, L., HILL, D., BLOCK, C., ID, D.G. Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer 2019;69:1–14. - PubMed
  26. 26. KURK, S., PEETERS, P., STELLATO, R., DORRESTEIJN, B., DE JONG, P., JOURDAN, M., et al. Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients. J. Cachexia. Sarcopenia Muscle 2019;10(4). - PubMed
  27. 27. DOLAN, D.R., KNIGHT, K.A., MAGUIRE, S., MOUG, S.J. The relationship between sarcopenia and survival at 1 year in patients having elective colorectal cancer surgery. Tech. Coloproctol. 2019;23(9). - PubMed
  28. 28. BROUGHMAN, J.R., WILLIAMS, G.R., DEAL, A.M., YU, H., NYROP, K.A., ALSTON, S.M., et al. Prevalence of sarcopenia in older patients with colorectal cancer. J. Geriatr. Oncol. 2015;6(6). - PubMed
  29. 29. CHOI, M.H., OH, S.N., LEE, I.K., OH, S.T., WON, D.D. Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer. J. Cachexia. Sarcopenia Muscle 2018;9(1). - PubMed
  30. 30. LIEFFERS, J.R., BATHE, O.F., FASSBENDER, K., WINGET, M., BARACOS, V.E. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br. J. Cancer 2012;107(6). - PubMed
  31. 31. RICHARDS, C.H., ROXBURGH, C.S.D., MACMILLAN, M.T., ISSWIASI, S., ROBERTSON, E.G., GUTHRIE, G.K., et al. The Relationships between Body Composition and the Systemic Inflammatory Response in Patients with Primary Operable Colorectal Cancer. PLoS One 2012;7(8):e41883. - PubMed
  32. 32. TAKEDA, Y., AKIYOSHI, T., MATSUEDA, K., FUKUOKA, H., OGURA, A., MIKI, H., et al. Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy. PLoS One 2018;13(4):e0195406. - PubMed
  33. 33. ONISHI, S., SHIRAKI, M., NISHIMURA, K., HANAI, T., MORIWAKI, H., SHIMIZU, M. Prevalence of sarcopenia and its relationship with nutritional state and quality of life in patients with digestive diseases. J. Nutr. Sci. Vitaminol. (Tokyo). 2018;64(6). - PubMed
  34. 34. SAKAMOTO, T., YAGYU, T., UCHINAKA, E., MIYATANI, K., HANAKI, T., KIHARA, K., et al. Sarcopenia as a prognostic factor in patients with recurrent pancreatic cancer: A retrospective study. World J. Surg. Oncol. 2020;18(1). - PubMed
  35. 35. NAUMANN, P., EBERLEIN, J., FARNIA, B., HACKERT, T., DEBUS, J., COMBS, S.E. Continued weight loss and sarcopenia predict poor outcomes in locally advanced pancreatic cancer treated with chemoradiation. Cancers (Basel). 2019;11(5). - PubMed
  36. 36. GRUBER, E.S., JOMRICH, G., TAMANDL, D., GNANT, M., SCHINDL, M., SAHORA, K. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma. PLoS One 2019;14(5). - PubMed
  37. 37. AMRANI, M. EL, VERMERSCH, M., FULBERT, M., PRODEAU, M., LECOLLE, K., HEBBAR, M., et al. Impact of sarcopenia on outcomes of patients undergoing pancreatectomy a retrospective analysis of 107 patients. Med. (United States) 2018;97(39). - PubMed
  38. 38. VAN DIJK, D.P.J., BAKENS, M.J.A.M., COOLSEN, M.M.E., RENSEN, S.S., VAN DAM, R.M., BOURS, M.J.L., et al. Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer. J. Cachexia. Sarcopenia Muscle 2017;8(2). - PubMed
  39. 39. NINOMIYA, G., FUJII, T., YAMADA, S., YABUSAKI, N., SUZUKI, K., IWATA, N., et al. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study. Int. J. Surg. 2017;39. - PubMed
  40. 40. PENG, P., HYDER, O., FIROOZMAND, A., KNEUERTZ, P., SCHULICK, R.D., HUANG, D., et al. Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma. J. Gastrointest. Surg. 2012;16(8). - PubMed
  41. 41. CHOI, Y., OH, D.-Y., KIM, T.-Y., LEE, K.-H., HAN, S.-W., IM, S.-A., et al. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index. PLoS One 2015;10(10):e0139749. - PubMed
  42. 42. HA, Y., KIM, D., HAN, S., CHON, Y.E., LEE, Y. BIN, KIM, M.N., et al. Sarcopenia predicts prognosis in patients with newly diagnosed hepatocellular carcinoma, independent of tumor stage and liver function. Cancer Res. Treat. 2018;50(3). - PubMed
  43. 43. BEGINI, P., GIGANTE, E., ANTONELLI, G., CARBONETTI, F., IANNICELLI, E., ANANIA, G., et al. Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis. Ann. Hepatol. 2017;16(1). - PubMed
  44. 44. TAKAGI, K., YAGI, T., YOSHIDA, R., SHINOURA, S., UMEDA, Y., NOBUOKA, D., et al. Sarcopenia and American society of anesthesiologists physical status in the assessment of outcomes of hepatocellular carcinoma patients undergoing hepatectomy. Acta Med. Okayama 2016;70(5). - PubMed
  45. 45. ZHOU, G., BAO, H., ZENG, Q., HU, W., ZHANG, Q. Sarcopenia as a prognostic factor in Hepatolithiasis-associated intrahepatic cholangiocarcinoma patients following hepatectomy: A retrospective study. Int. J. Clin. Exp. Med. 2015;8(10). - PubMed
  46. 46. VAN VUGT, J.L.A., GASPERSZ, M.P., VUGTS, J., BUETTNER, S., LEVOLGER, S., DE BRUIN, R.W.F., et al. Low Skeletal Muscle Density Is Associated with Early Death in Patients with Perihilar Cholangiocarcinoma Regardless of Subsequent Treatment. Dig. Surg. 2019;36(2). - PubMed
  47. 47. VAN VUGT, J.L.A., BUETTNER, S., LEVOLGER, S., COEBERGH VAN DEN BRAAK, R.R.J., SUKER, M., GASPERSZ, M.P., et al. Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract. PLoS One 2017;12(10). - PubMed
  48. 48. CHOI, M.H., YOON, S.B., LEE, K., SONG, M., LEE, I.S., LEE, M.A., et al. Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer. J. Cachexia. Sarcopenia Muscle 2018;9(2). - PubMed
  49. 49. SIMONSEN, C., DE HEER, P., BJERRE, E.D., SUETTA, C., HOJMAN, P., PEDERSEN, B.K., et al. Sarcopenia and Postoperative Complication Risk in Gastrointestinal Surgical Oncology. Ann. Surg. 2018;268(1):58–69. - PubMed
  50. 50. PANJE, C.M., HÖNG, L., HAYOZ, S., BARACOS, V.E., HERRMANN, E., GARCIA SCHÜLER, H., et al. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy. Radiat. Oncol. 2019;14(1). - PubMed
  51. 51. YAMAMOTO, K., NAGATSUMA, Y., FUKUDA, Y., HIRAO, M., NISHIKAWA, K., MIYAMOTO, A., et al. Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer. Gastric Cancer 2017;20(5). - PubMed
  52. 52. VAN VUGT, J.L.A., LEVOLGER, S., GHARBHARAN, A., KOEK, M., NIESSEN, W.J., BURGER, J.W.A., et al. A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients. J. Cachexia. Sarcopenia Muscle 2017;8(2). - PubMed

Publication Types